Human cytomegalovirus UL97 phosphorylates the viral nuclear egress complex

Journal of Virology

Volumn 89, Issue 1, 2015, Pages 523-534

  Sharma, Mayuri ^a   Bender, Brian J ^a,b   Kamil, Jeremy P ^a,c   Lye, Ming F ^a   Pesola, Jean M ^a   Reim, Natalia I ^a   Hogle, James M ^a   Coen, Donald M ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZIMIDAVIR; LAMIN A; LAMIN C; UL97 PROTEIN; UNCLASSIFIED DRUG; VIRUS ENZYME; VIRUS PROTEIN; GANCICLOVIR KINASE; LMNA PROTEIN, HUMAN; PHOSPHOTRANSFERASE;

ARTICLE; BIRTH DEFECT; CELL NUCLEUS; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; HERPESVIRIDAE; HUMAN CYTOMEGALOVIRUS; IMMUNOPRECIPITATION; IN VITRO STUDY; MASS SPECTROMETRY; NONHUMAN; NUCLEAR LAMINA; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PURIFICATION; VIRUS NUCLEOCAPSID; VIRUS REPLICATION; CYTOMEGALOVIRUS; HOST PATHOGEN INTERACTION; HUMAN; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN PROCESSING; VIROLOGY; VIRUS RELEASE;

HERPESVIRIDAE; HUMAN HERPESVIRUS 5;

CELL NUCLEUS; CYTOMEGALOVIRUS; HOST-PATHOGEN INTERACTIONS; HUMANS; LAMIN TYPE A; MASS SPECTROMETRY; PHOSPHORYLATION; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); PROTEIN PROCESSING, POST-TRANSLATIONAL; VIRAL PROTEINS; VIRUS RELEASE;

EID: 84919459578     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02426-14     Document Type: Article

References (58)

1. Mettenleiter TC, Klupp BG, Granzow H. 2006. Herpesvirus assembly: a tale of two membranes. Curr Opin Microbiol 9:423-429. http://dx.doi.org/10.1016/j.mib.2006.06.013.
2. Mettenleiter TC, Minson T. 2006. Egress of alphaherpesviruses. J Virol 80:1610-1611. http://dx.doi.org/10.1128/JVI.80.3.1610-1612.2006.
3. Mettenleiter TC. 2002. Herpesvirus assembly and egress. J Virol 76:1537-1547. http://dx.doi.org/10.1128/JVI.76.4.1537-1547.2002.
4. Britt W. 2008. Manifestations of human cytomegalovirus infection: proposed mechanisms of acute and chronic disease. Curr Top Microbiol Immunol 325:417-470. http://dx.doi.org/10.1007/978-3-540-77349-8_23.
5. Mercorelli B, Lembo D, Palu G, Loregian A. 2011. Early inhibitors of human cytomegalovirus: state-of-art and therapeutic perspectives. Pharmacol Ther 131:309-329. http://dx.doi.org/10.1016/j.pharmthera.2011.04.007.
6. Pultoo A, Jankee H, Meetoo G, Pyndiah MN, Khittoo G. 2000. Detection of cytomegalovirus in urine of hearing-impaired and mentally retarded children by PCR and cell culture. J Commun Dis 32:101-108.
7. Hakki M, Chou S. 2011. The biology of cytomegalovirus drug resistance. Curr Opin Infect Dis 24:605-611. http://dx.doi.org/10.1097/QCO.0b013e32834cfb58.
8. Sharma M, Kamil JP, Coughlin M, Reim NI, Coen DM. 2014. Human cytomegalovirus UL50 and UL53 recruit viral protein kinase UL97, not protein kinase C, for disruption of nuclear lamina and nuclear egress in infected cells. J Virol 88:249-262. http://dx.doi.org/10.1128/JVI.02358-13.
9. Sharma M, Coen DM. 2014. Comparison of effects of inhibitors of viral and cellular protein kinases on human cytomegalovirus disruption of nuclear lamina and nuclear egress. J Virol 88:10982-10985. http://dx.doi.org/10.1128/JVI.01391-14.
10. Krosky PM, Baek MC, Coen DM. 2003. The human cytomegalovirus UL97 protein kinase, an antiviral drug target, is required at the stage of nuclear egress. J Virol 77:905-914. http://dx.doi.org/10.1128/JVI.77.2.905-914.2003.
11. Hamirally S, Kamil JP, Ndassa-Colday YM, Lin AJ, Jahng WJ, Baek MC, Noton S, Silva LA, Simpson-Holley M, Knipe DM, Golan DE, Marto JA, Coen DM. 2009. Viral mimicry of Cdc2/cyclin-dependent kinase 1 mediates disruption of nuclear lamina during human cytomegalovirus nuclear egress. PLoS Pathog 5:e1000275. http://dx.doi.org/10.1371/journal.ppat.1000275.
12. Wolf DG, Courcelle CT, Prichard MN, Mocarski ES. 2001. Distinct and separate roles for herpesvirus-conserved UL97 kinase in cytomegalovirus DNA synthesis and encapsidation. Proc Natl Acad Sci USA 98:1895-1900. http://dx.doi.org/10.1073/pnas.98.4.1895.
13. Azzeh M, Honigman A, Taraboulos A, Rouvinski A, Wolf DG. 2006. Structural changes in human cytomegalovirus cytoplasmic assembly sites in the absence of UL97 kinase activity. Virology 354:69-79. http://dx.doi.org/10.1016/j.virol.2006.05.037.
14. Goldberg MD, Honigman A, Weinstein J, Chou S, Taraboulos A, Rouvinski A, Shinder V, Wolf DG. 2011. Human cytomegalovirus UL97 kinase and nonkinase functions mediate viral cytoplasmic secondary envelopment. J Virol 85:3375-3384. http://dx.doi.org/10.1128/JVI.01952-10.
15. Kamil JP, Coen DM. 2007. Human cytomegalovirus protein kinase UL97 forms a complex with the tegument phosphoprotein pp65. J Virol 81: 10659-10668. http://dx.doi.org/10.1128/JVI.00497-07.
16. Kamil JP, Hume AJ, Jurak I, Munger K, Kalejta RF, Coen DM. 2009. Human papillomavirus 16 E7 inactivator of retinoblastoma family proteins complements human cytomegalovirus lacking UL97 protein kinase. Proc Natl Acad Sci USA 106:16823-16828. http://dx.doi.org/10.1073/pnas.0901521106.
17. Reim NI, Kamil JP, Wang D, Lin A, Sharma M, Ericsson M, Pesola JM, Golan DE, Coen DM. 2013. Inactivation of retinoblastoma protein does not overcome the requirement for human cytomegalovirus UL97 in lamina disruption and nuclear egress. J Virol 87:5019-5027. http://dx.doi.org/10.1128/JVI.00007-13.
18. Hume AJ, Finkel JS, Kamil JP, Coen DM, Culbertson MR, Kalejta RF. 2008. Phosphorylation of retinoblastoma protein by viral protein with cyclin-dependent kinase function. Science 320:797-799. http://dx.doi.org/10.1126/science.1152095.
19. Baek MC, Krosky PM, Pearson A, Coen DM. 2004. Phosphorylation of the RNA polymerase II carboxyl-terminal domain in human cytomegalovirus-infected cells and in vitro by the viral UL97 protein kinase. Virology 324:184-193. http://dx.doi.org/10.1016/j.virol.2004.03.015.
20. Silva LA, Strang BL, Lin EW, Kamil JP, Coen DM. 2011. Sites and roles of phosphorylation of the human cytomegalovirus DNA polymerase subunit UL44. Virology 417:268-280. http://dx.doi.org/10.1016/j.virol.2011.06.008.
21. Bigley TM, Reitsma JM, Mirza SP, Terhune SS. 2013. Human cytomegalovirus pUL97 regulates the viral major immediate early promoter by phosphorylation-mediated disruption of histone deacetylase 1 binding. J Virol 87:7393-7408. http://dx.doi.org/10.1128/JVI.02825-12.
22. Kawaguchi Y, Matsumura T, Roizman B, Hirai K. 1999. Cellular elongation factor 1δ is modified in cells infected with representative alpha-, beta-, or gammaherpesviruses. J Virol 73:4456-4460.
23. Marschall M, Marzi A, Aus Dem Siepen P, Jochmann R, Kalmer M, Auerochs S, Lischka P, Leis M, Stamminger T. 2005. Cellular p32 recruits cytomegalovirus kinase pUL97 to redistribute the nuclear lamina. J Biol Chem 280:33357-33367. http://dx.doi.org/10.1074/jbc.M502672200.
24. Tran K, Mahr JA, Choi J, Teodoro JG, Green MR, Spector DH. 2008. Accumulation of substrates of the anaphase-promoting complex (APC) during human cytomegalovirus infection is associated with the phosphorylation of Cdh1 and the dissociation and relocalization of APC subunits. J Virol 82:529-537. http://dx.doi.org/10.1128/JVI.02010-07.
25. Krosky PM, Baek MC, Jahng WJ, Barrera I, Harvey RJ, Biron KK, Coen DM, Sethna PB. 2003. The human cytomegalovirus UL44 protein is a substrate for the UL97 protein kinase. J Virol 77:7720-7727. http://dx.doi.org/10.1128/JVI.77.14.7720-7727.2003.
26. Tran K, Kamil JP, Coen DM, Spector DH. 2010. Inactivation and disassembly of the anaphase-promoting complex during human cytomegalovirus infection is associated with degradation of the APC5 and APC4 subunits and does not require UL97-mediated phosphorylation of Cdh1. J Virol 84:10832-10843. http://dx.doi.org/10.1128/JVI.01260-10.
27. Milbradt J, Auerochs S, Marschall M. 2007. Cytomegaloviral proteins pUL50 and pUL53 are associated with the nuclear lamina and interact with cellular protein kinase C. J Gen Virol 88:2642-2650. http://dx.doi.org/10.1099/vir.0.82924-0.
28. Camozzi D, Pignatelli S, Valvo C, Lattanzi G, Capanni C, Dal Monte P, Landini MP. 2008. Remodelling of the nuclear lamina during human cytomegalovirus infection: role of the viral proteins pUL50 and pUL53. J Gen Virol 89:731-740. http://dx.doi.org/10.1099/vir.0.83377-0.
29. Klupp BG, Granzow H, Fuchs W, Keil GM, Finke S, Mettenleiter TC. 2007. Vesicle formation from the nuclear membrane is induced by coexpression of two conserved herpesvirus proteins. Proc Natl Acad Sci USA 104:7241-7246. http://dx.doi.org/10.1073/pnas.0701757104.
30. Bigalke JM, Heuser T, Nicastro D, Heldwein EE. 2014. Membrane deformation and scission by the HSV-1 nuclear egress complex. Nat Commun 5:4131. http://dx.doi.org/10.1038/ncomms5131.
31. Popa M, Ruzsics Z, Lotzerich M, Dolken L, Buser C, Walther P, Koszinowski UH. 2010. Dominant negative mutants of the murine cytomegalovirus M53 gene block nuclear egress and inhibit capsid maturation. J Virol 84:9035-9046. http://dx.doi.org/10.1128/JVI.00681-10.
32. Hobom U, Brune W, Messerle M, Hahn G, Koszinowski UH. 2000. Fast screening procedures for random transposon libraries of cloned herpesvirus genomes: mutational analysis of human cytomegalovirus envelope glycoprotein genes. J Virol 74:7720-7729. http://dx.doi.org/10.1128/JVI.74.17.7720-7729.2000.
33. Tischer BK, Smith GA, Osterrieder N. 2010. En passant mutagenesis: a two step markerless red recombination system. Methods Mol Biol 634: 421-430. http://dx.doi.org/10.1007/978-1-60761-652-8_30.
34. Tischer BK, von Einem J, Kaufer B, Osterrieder N. 2006. Two-step red-mediated recombination for versatile high-efficiency markerlessDNA manipulation in Escherichia coli. Biotechniques 40:191-197. http://dx.doi.org/10.2144/000112096.
35. Baldick CJ, Jr, Marchini A, Patterson CE, Shenk T. 1997. Human cytomegalovirus tegument protein pp71 (ppUL82) enhances the infectivity of viralDNAand accelerates the infectious cycle. J Virol 71:4400-4408.
36. Wessel D, Flugge UI. 1984. A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids. Anal Biochem 138:141-143. http://dx.doi.org/10.1016/0003-2697(84)90782-6.
37. Sam MD, Evans BT, Coen DM, Hogle JM. 2009. Biochemical, biophysical, and mutational analyses of subunit interactions of the human cytomegalovirus nuclear egress complex. J Virol 83:2996-3006. http://dx.doi.org/10.1128/JVI.02441-08.
38. Izumi M, Vaughan OA, Hutchison CJ, Gilbert DM. 2000. Head and/or CaaX domain deletions of lamin proteins disrupt preformed lamin A and C but not lamin B structure in mammalian cells. Mol Biol Cell 11:4323-4337. http://dx.doi.org/10.1091/mbc.11.12.4323.
39. Milbradt J, Webel R, Auerochs S, Sticht H, Marschall M. 2010. Novel mode of phosphorylation-triggered reorganization of the nuclear lamina during nuclear egress of human cytomegalovirus. J Biol Chem 285:13979-13989. http://dx.doi.org/10.1074/jbc.M109.063628.
40. Biron KK, Harvey RJ, Chamberlain SC, Good SS, Smith AA, III, Davis MG, Talarico CL, Miller WH, Ferris R, Dornsife RE, Stanat SC, Drach J C, Townsend LB, Koszalka GW. 2002. Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole L-riboside with a unique mode of action. Antimicrob Agents Chemother 46: 2365-2372. http://dx.doi.org/10.1128/AAC.46.8.2365-2372.2002.
41. He Z, He YS, Kim Y, Chu L, Ohmstede C, Biron KK, Coen DM. 1997. The human cytomegalovirus UL97 protein is a protein kinase that autophosphorylates on serines and threonines. J Virol 71:405-411.
42. Baek MC, Krosky PM, Coen DM. 2002. Relationship between autophosphorylation and phosphorylation of exogenous substrates by the human cytomegalovirus UL97 protein kinase. J Virol 76:11943-11952. http://dx.doi.org/10.1128/JVI.76.23.11943-11952.2002.
43. Schmeiser C, Borst E, Sticht H, Marschall M, Milbradt J. 2013. The cytomegalovirus egress proteins pUL50 and pUL53 are translocated to the nuclear envelope through two distinct modes of nuclear import. J Gen Virol 94:2056-2069. http://dx.doi.org/10.1099/vir.0.052571-0.
44. Rupp B, Ruzsics Z, Buser C, Adler B, Walther P, Koszinowski UH. 2007. Random screening for dominant-negative mutants of the cytomegalovirus nuclear egress protein M50. J Virol 81:5508-5517. http://dx.doi.org/10.1128/JVI.02796-06.
45. Buser C, Fleischer F, Mertens T, Michel D, Schmidt V, Walther P. 2007. Quantitative investigation of murine cytomegalovirus nucleocapsid interaction. J Microsc 228:78-87. http://dx.doi.org/10.1111/j.1365-2818.2007.01825.x.
46. Mou F, Wills EG, Park R, Baines JD. 2008. Effects of lamin A/C, lamin B1, and viral US3 kinase activity on viral infectivity, virion egress, and the targeting of herpes simplex virus U(L)34-encoded protein to the inner nuclear membrane. J Virol 82:8094-8104. http://dx.doi.org/10.1128/JVI.00874-08.
47. Speese SD, Ashley J, Jokhi V, Nunnari J, Barria R, Li Y, Ataman B, Koon A, Chang YT, Li Q, Moore MJ, Budnik V. 2012. Nuclear envelope budding enables large ribonucleoprotein particle export during synaptic Wnt signaling. Cell 149:832-846. http://dx.doi.org/10.1016/j.cell.2012.03.032.
48. Mou F, Wills E, Baines JD. 2009. Phosphorylation of the U(L)31 protein of herpes simplex virus 1 by the U(S)3-encoded kinase regulates localization of the nuclear envelopment complex and egress of nucleocapsids. J Virol 83:5181-5191. http://dx.doi.org/10.1128/JVI.00090-09.
49. Ryckman BJ, Roller RJ. 2004. Herpes simplex virus type 1 primary envelopment: UL34 protein modification and the US3-UL34 catalytic relationship. J Virol 78:399-412. http://dx.doi.org/10.1128/JVI.78.1.399-412.2004.
50. Purves FC, Spector D, Roizman B. 1991. The herpes simplex virus 1 protein kinase encoded by the US3 gene mediates posttranslational modification of the phosphoprotein encoded by the UL34 gene. J Virol 65: 5757-5764.
51. Kato A, Yamamoto M, Ohno T, Tanaka M, Sata T, Nishiyama Y, Kawaguchi Y. 2006. Herpes simplex virus 1-encoded protein kinase UL13 phosphorylates viral Us3 protein kinase and regulates nuclear localization of viral envelopment factors UL34 and UL31. J Virol 80:1476-1486. http://dx.doi.org/10.1128/JVI.80.3.1476-1486.2006.
52. Morrison LA, DeLassus GS. 2011. Breach of the nuclear lamina during assembly of herpes simplex viruses. Nucleus 2:271-276. http://dx.doi.org/10.4161/nucl.2.4.16334.
53. Klupp BG, Granzow H, Mettenleiter TC. 2001. Effect of the pseudorabies virus US3 protein on nuclear membrane localization of the UL34 protein and virus egress from the nucleus. J Gen Virol 82:2363-2371.
54. Purves FC, Longnecker RM, Leader DP, Roizman B. 1987. Herpes simplex virus 1 protein kinase is encoded by open reading frame US3 which is not essential for virus growth in cell culture. J Virol 61:2896-2901.
55. Kimman TG, De Wind N, De Bruin T, de Visser Y, Voermans J. 1994. Inactivation of glycoprotein gE and thymidine kinase or the US3-encoded protein kinase synergistically decreases in vivo replication of pseudorabies virus and the induction of protective immunity. Virology 205:511-518. http://dx.doi.org/10.1006/viro.1994.1672.
56. Morimoto T, Arii J, Tanaka M, Sata T, Akashi H, Yamada M, Nishiyama Y, Uema M, Kawaguchi Y. 2009. Differences in the regulatory and functional effects of the Us3 protein kinase activities of herpes simplex virus 1 and 2. J Virol 83:11624-11634. http://dx.doi.org/10.1128/JVI.00993-09.
57. Nishiyama Y, Yamada Y, Kurachi R, Daikoku T. 1992. Construction of a US3 lacZ insertion mutant of herpes simplex virus type 2 and characterization of its phenotype in vitro and in vivo. Virology 190:256-268. http://dx.doi.org/10.1016/0042-6822(92)91212-D.
58. Reynolds AE, Wills EG, Roller RJ, Ryckman BJ, Baines JD. 2002. Ultrastructural localization of the herpes simplex virus type 1 UL31, UL34, and US3 proteins suggests specific roles in primary envelopment and egress of nucleocapsids. J Virol 76:8939-8952. http://dx.doi.org/10.1128/JVI.76.17.8939-8952.2002.